The move comes at time when Bitcoin trading volumes have seen up to 80% declines since early , with CBOE XBT products failing to generate more than $1B in notional trading volume since May The Cboe halts Bitcoin futures blockchain is a public ledger that records bitcoin transactions. It is implemented Eastern Samoa a chain of blocks, each block containing letter hash of the preceding impedimenta up to the book block of the chain. Jun 10, · Chicago Board Options Exchange (CBOE), the world’s largest options market, will reportedly settle the last Bitcoin futures contract on June With the expiration of .
Cboe trading halt bitcoinCBOE Stops Offering Bitcoin Futures (And That's Probably a Good Thing) - crypmoney.de
Doom, slams Bitcoin and other cryptocurrencies as being driven by manipulation. Since then, its stock has taken a remarkable rise. Why is a bit of a mystery. A series of events — allegations of fraud committed by founder Trevor Milton, his subsequent resignation, a severely underwhelming deal with General Motors — have sent investors to the exit gates.
Now it looks like even the trash wants nothing to do with Nikola. On Wednesday, the company announced that its plan to design and build BEV garbage refuse trucks for waste collection company Republic Services has collapsed. The company has cited that the cost to build the trucks would be higher than expected and would take too long, after both sides concluded that building the refuse truck using the Nikola Tre as its base would not work.
Disclaimer: The opinions expressed in this article are solely those of the featured analyst. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Chinese authorities investigate an e-commerce giant, Google may be tightening its grip on research and VCs weigh in on the year's biggest surprises.
China's State Administration for Market Regulation said that it's investigating the e-commerce giant over a policy that forces merchants to sell exclusively with Alibaba and skip rival platforms JD. Affiliate Ant Group Co. Roughly million shares exchanged hands, the most for a single session since its debut. Alibaba said in a statement it will cooperate with regulators in their investigation, and that its operations remain normal. Ant said in a statement on its official WeChat account it will study and comply with all requirements.
As of early December, the man most closely identified with the meteoric rise of China Inc. His very public rebuke is instead a warning Beijing has lost patience with the outsize power of its technology moguls, increasingly perceived as a threat to the political and financial stability President Xi Jinping prizes most.
Tencent and internet services giant Meituan finished more than 2. The regulations specifically warn against selling at below-cost to weed out rivals. The mouthpiece of the Communist Party said in a commentary Friday that Chinese internet companies should regard the inquiry into Alibaba as an opportunity to improve their awareness of fair competition and anti-monopoly practices. The chances that Ant will be able to revive its massive stock listing next year are looking increasingly slim as China overhauls rules governing the fintech industry, which in past years has boomed as an alternative to traditional state-backed lending.
China is said to have separately set up a joint task force to oversee Ant, led by the Financial Stability and Development Committee, a financial system regulator, along with various departments of the central bank and other regulators.
The group is in regular contact with Ant to collect data and other materials, studying its restructuring as well as drafting other rules for the fintech industry. What Happened: On Wednesday, Inovio published a paper including Phase 1 data on INO, which was found to have been immunogenic in all test subjects.
In addition, Phase 1 testing generated no serious adverse safety events and only six Grade I adverse events, which were mostly minor injection site reactions. Yet Moderna's vaccine must be stored and transported at temperatures of negative 20 Celsius, and Pfizer's vaccine must be stored and transported at temperatures of negative 70 Celsius, colder than winter temperatures in Antarctica.
INO, on the other hand, is stable at room temperature for more than one year. It also doesn't need to be frozen during transporter storage, potentially making it faster and more cost-effective to distribute.
Benzinga's Take: Assuming it is as effective and safe as competing vaccines, Inovio's candidate could ultimately end up being the standard-bearer for COVID and future coronavirus vaccine variants. These are the top dividend stocks in the Russell with the highest forward dividend yield for January. First thing's first, what are penny stocks? Penny stocks are well-known for their volatility aside from just their cheap price. First, understand what you're buying and why you're buying it.
Just saying you trade penny stocks isn't the goal. You're in the market to make money. So, identifying entry and exit targets are obviously important. What's more, is you should have a basic strategy in mind. Are you looking at day trading penny stocks or do you have a longer-term idea in mind? Also, it's important to account for the swings in price and how fast they're happening. Case in point, small-cap stocks are red hot right now.
When finding penny stocks to buy, make sure you assess each trade independently and plan accordingly. Furthermore, day traders wouldn't normally jump into a stock that is barely fluctuating in price. As a rule of thumb, the lower the price, the higher the volatility. That's simply for the fact that a small move in price equates to a larger percentage change.
This week the company came out with news that it finished the purchase of roughly 44 acres in Montana. This will be the site for its vaccine development and manufacturing facility.
This adds to the growing footprint of the company as well. These two facilities will support the development and production of the company's vaccine candidates. Specifically, the TNX has been a center of attention as you could imagine. Many coronavirus vaccine stocks have garnered interest over the last few months. In this case, Tonix is aiming to report efficacy data from animal challenge studies of the vaccine candidate next quarter. Unlike other biotech's Biolase is mainly focused on products used in oral health.
The company's main products are dental laser systems that perform a wide range of procedures, including cosmetic and complex surgical applications.
Last month the company launched Waterlase Endo Academy to foster education and best practices for integrating Waterlase technology in clinical settings. Jaguar Health Inc. While we've reported on the company for weeks, the bigger move this week comes after Jaguar's latest update. The company signed an agreement for a non-dilutive royalty financing transaction. Lisa Conte, Jaguar's president and CEO, explained that, "The timing of this transaction aligns well with the progress of the recently initiated pivotal Phase 3 trial for CTD, for which patient enrollment is progressing.
There's a potential deal with the SPAC and an operational subsidiary of Jaguar to be established in Europe with an exclusive license to crofelemer and Mytesi for the indications of inflammatory diarrhea and HIV-related diarrhea. Senseonics Holdings Inc. Senseonics was granted a patent titled, "Remotely-powered sensing system with multiple sensing devices. Senseonics' implantable glucose monitoring systems are used by diabetes patients. This communicates with a smart transmitter worn over the sensor.
Data are then sent every five minutes to a mobile app on the user's smartphone. Adding to the reasons to watch Senseonics, earlier this year the company entered a collaboration with Ascensia Diabetes Care, a global diabetes care company.
Heading into the beginning of , there are a few things traders are following. One of these things is the initiation of commercial activities outside of the US with the help of Ascensia. The company also expects a decision on approval of its Eversense product by the FDA in the first half of the year. Neither the author of this post nor Pennystocks. Finally, a chance that the lockdown and social distancing regimes truly are going to end, and in the near-term.
There is a real chance that, by the end of a , John Q. Public may be getting back on his feet. A return to grass roots normalcy will be great — but we also have the prospect of an overall rising market.
Risks relating to global trade tensions, political uncertainty, and the pandemic, will be going away. Sotera Health SHC Sotera Health occupies a unique niche in the healthcare industry, offering, through its subsidiaries, a range of safety-oriented support businesses for healthcare providers. These services include sterilization procedures, lab testing, and advisory services — and their importance is immediately clear.
Sotera boasts over 5, healthcare provider customers in more than 50 countries around the world. While not a new company — two of its branches have been in business since the s and 40s — Sotera is new to the stock markets, having held its IPO just this past November. That facility is currently undrawn. This clinical research biopharma company focuses on major issues of reproductive system disease in both men and women. Specifically, Myovant is working to develop treatments for uterine fibroids, endometriosis, and prostate cancer.
The drug is in Phase 3 trial for the latter, and has had its NDA submitted for the former. Also in the pipeline, and related to reproductive health, is MVT, a new drug designed to enhance egg maturation and aid in vitro fertilization.
In addition, Myovant has announced this month that Relugolix has been FDA approved — under the brand name Orgovyx — as a treatment for advanced prostate cancer. Orgovyx is expected to enter the market in January Further, we see an attractive commercial setup for relugolix in the treatment of advanced prostate cancer as an oral LHRH alternative with a differentiated CV risk profile.
In a year that has been difficult for most of us, MCB has managed to post steadily increasing revenues and solid earnings. In this environment, he sees Metropolitan Bank as the right choice.
Having witnessed many cycles in NYC, the time to buy has been when the herd is running in the other direction. Alexopoulos' is the only recent analyst review of this company, and it is decidedly positive. Ah, "Carnival. And some cruise lines are about to resume trips. So is this a good time or bad time to invest in Carnival?
Dow 30 30, Nasdaq 12, Russell 2, Crude Oil Gold 1, Silver CMC Crypto FTSE 6, Nikkei 26, Read full article. Oliver Knight March 15, , PM. Story continues. Latest Stories. Yahoo Finance. Investor's Business Daily.
Then the company stated:. CFE is assessing its approach with respect to how it plans to continue to offer digital asset derivatives for trading. While it considers its next steps, CFE does not currently intend to list additional XBT futures contracts for trading. Moreover, on May 13, CME Group reached a record high volume of 33, contracts for Bitcoin, processing more than a billion dollars in a single day. While CBOE was relying only on Gemini listing, CME was collecting the data from several marketplaces, which resulted in the growing confidence of traders in the trustworthiness of the exchange.
Eugenia can call herself a multy-interested person, as she is always in search of new proffessional fields to encompass. After graduating from Belarussian State University with Bachelor degree in both International Communication and Public Relations, she joined a travel startup Fresh Adventures, where she worked for 3 years creating unique itineraries through exotic countries, travelling around the world and developing the company as a partner.
Currently, she works as a business analyst in the field of information technologies. She believes that IT is the future, that is why it is so important to keep up with the latest trends in this rapidly growing industry. Author Eugenia Kovaliova.